Organization
Yale-New Haven Health
1 abstract
Abstract
Decreased HER2 expression in residual disease following neoadjuvant therapy in patients with HER2-positive breast cancer.Org: Yale-New Haven Health, Yale University School of Medicine,
1 abstract